Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Janmejay Singh"'
Autor:
Zaigham Abbas Rizvi, Jyotsna Dandotiya, Srikanth Sadhu, Ritika Khatri, Janmejay Singh, Virendra Singh, Neeta Adhikari, Kritika Sharma, Vinayake Das, Amit Kumar Pandey, Bhabatosh Das, Guruprasad Medigeshi, Shalendra Mani, Shinjini Bhatnagar, Sweety Samal, Anil Kumar Pandey, Pramod Kumar Garg, Amit Awasthi
Publikováno v:
Communications Biology, Vol 6, Iss 1, Pp 1-14 (2023)
Abstract A recently emerged sub-lineage of Omicron, BA.5, together with BA.4, caused a fifth wave of coronavirus disease (COVID-19) in South Africa and subsequently emerged as a predominant strain globally due to its high transmissibility. The lethal
Externí odkaz:
https://doaj.org/article/fa2213b252c144c39434f971c7aca2bd
Autor:
Suman Das, Janmejay Singh, Heena Shaman, Balwant Singh, Anbalagan Anantharaj, Patil Sharanabasava, Rajesh Pandey, Rakesh Lodha, Anil Kumar Pandey, Guruprasad R. Medigeshi
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-7 (2022)
Serosurveillance studies show a heterogenous mix of the Indian population with immunity to COVID-19 due to vaccination or natural infection. Here, the authors enrol subjects representative of the general population, to assess whether pre-existing ant
Externí odkaz:
https://doaj.org/article/9f137a18f4f940adb91abc76b8797ea6
Autor:
Janmejay Singh, Anbalagan Anantharaj, Aleksha Panwar, Chitra Rani, Monika Bhardwaj, Parveen Kumar, Partha Chattopadhyay, Priti Devi, Ranjeet Maurya, Pallavi Mishra, Anil Kumar Pandey, Rajesh Pandey, Guruprasad R Medigeshi
Publikováno v:
PLoS Pathogens, Vol 19, Iss 2, p e1011196 (2023)
The Omicron variant of SARS-CoV-2 is capable of infecting unvaccinated, vaccinated and previously-infected individuals due to its ability to evade neutralization by antibodies. With multiple sub-lineages of Omicron emerging in the last 12 months, the
Externí odkaz:
https://doaj.org/article/f1db0a193d7d4de08701bf1beb080344
Autor:
Subhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, Vijay Yerroju, Rammohan Mogulla, Pothakamuri Venkata Suneetha, Kishore Turaga, Mahesh Kyasani, Senthil Kumar Manoharan, Srikanth Adabala, Aditya Sri Javvadi, Guruprasad Medigeshi, Janmejay Singh, Heena Shaman, Akshay Binayke, Aymaan Zaheer, Amit Awasthi, Chandramani Singh, Venkateshwar Rao A, Indranil Basu, Khobragade Akash Ashok Kumar, Anil Kumar Pandey
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)
Optimum formulation of Biological-E’s protein subunit CORBEVAX™ vaccine was selected in phase-1 and -2 studies and found to be safe and immunogenic in healthy adult population. This is a phase-3 prospective, single-blinded, randomized, active con
Externí odkaz:
https://doaj.org/article/0709ab9d4a18471087c28f5c42986c9f
Autor:
Hilal Ahmad Parray, Naveen Narayanan, Sonal Garg, Zaigham Abbas Rizvi, Tripti Shrivastava, Sachin Kushwaha, Janmejay Singh, Praveenkumar Murugavelu, Anbalagan Anantharaj, Farha Mehdi, Nisha Raj, Shivam Singh, Jyotsna Dandotiya, Asha Lukose, Deepti Jamwal, Sandeep Kumar, Adarsh K Chiranjivi, Samridhi Dhyani, Nitesh Mishra, Sanjeev Kumar, Kamini Jakhar, Sudipta Sonar, Anil Kumar Panchal, Manas Ranjan Tripathy, Shirlie Roy Chowdhury, Shubbir Ahmed, Sweety Samal, Shailendra Mani, Sankar Bhattacharyya, Supratik Das, Subrata Sinha, Kalpana Luthra, Gaurav Batra, Devinder Sehgal, Guruprasad R Medigeshi, Chandresh Sharma, Amit Awasthi, Pramod Kumar Garg, Deepak T Nair, Rajesh Kumar
Publikováno v:
PLoS Pathogens, Vol 18, Iss 12, p e1010994 (2022)
The emergence of new variants of SARS-CoV-2 necessitates unremitting efforts to discover novel therapeutic monoclonal antibodies (mAbs). Here, we report an extremely potent mAb named P4A2 that can neutralize all the circulating variants of concern (V
Externí odkaz:
https://doaj.org/article/3ba087963a9548d5823331f44d97566f
Autor:
Subhash Thuluva, Vikram Paradkar, Subba Reddy Gunneri, Vijay Yerroju, Rammohan Mogulla, Kishore Turaga, Mahesh Kyasani, Senthil Kumar Manoharan, Guruprasad Medigeshi, Janmejay Singh, Heena Shaman, Chandramani Singh, Venkateshwar Rao A
Publikováno v:
EBioMedicine, Vol 83, Iss , Pp 104217- (2022)
Summary: Background: We assessed the efficacy of a receptor-binding domain (RBD)-based protein subunit COVID-19 vaccine. Methods: A randomised Phase-1/2 trial followed by a Phase-2 trial were conducted to assess the safety and immunogenicity of the C
Externí odkaz:
https://doaj.org/article/c09306339bcf4672bbb23a9388a32a1a
Autor:
Guruprasad R Medigeshi, Gaurav Batra, Deepika Rathna Murugesan, Ramachandran Thiruvengadam, Souvick Chattopadhyay, Bhabatosh Das, Mudita Gosain, Ayushi, Janmejay Singh, Anantharaj Anbalagan, Heena Shaman, Kamal Pargai, Farha Mehdi, Soon Jyoti Das, Namrata Kahlon, Savita Singh, Pallavi Kshetrapal, Nitya Wadhwa, Anil K Pandey, Shinjini Bhatnagar, Pramod Kumar Garg
Publikováno v:
EBioMedicine, Vol 78, Iss , Pp 103938- (2022)
Summary: Background: Rapid spread of the omicron SARS-CoV-2 variant despite extensive vaccination suggests immune escape. The neutralising ability of different vaccines alone or with natural SARS-CoV-2 infection against omicron is not well-known. Met
Externí odkaz:
https://doaj.org/article/13fe215463cf4b84977eabc5ee354fc8
Autor:
Nitin Hingankar, Suprit Deshpande, Payel Das, Zaigham Abbas Rizvi, Constantinos Kurt Wibmer, Poppy Mashilo, Mohammed Yousuf Ansari, Alison Burns, Shawn Barman, Fangzhu Zhao, Sohini Mukherjee, Jonathan L Torres, Souvick Chattopadhyay, Farha Mehdi, Jyoti Sutar, Deepak Kumar Rathore, Kamal Pargai, Janmejay Singh, Sudipta Sonar, Kamini Jakhar, Jyotsna Dandotiya, Sankar Bhattacharyya, Shailendra Mani, Sweety Samal, Savita Singh, Pallavi Kshetrapal, Ramachandran Thiruvengadam, Gaurav Batra, Guruprasad Medigeshi, Andrew B Ward, Shinjini Bhatnagar, Amit Awasthi, Devin Sok, Jayanta Bhattacharya
Publikováno v:
PLoS Pathogens, Vol 18, Iss 4, p e1010465 (2022)
Although efficacious vaccines have significantly reduced the morbidity and mortality of COVID-19, there remains an unmet medical need for treatment options, which monoclonal antibodies (mAbs) can potentially fill. This unmet need is exacerbated by th
Externí odkaz:
https://doaj.org/article/a5a76225c38141629fe49e262e9a20b8
Autor:
Suprit Deshpande, Mohammed Yousuf Ansari, Jyoti Sutar, Payel Das, Nitin Hingankar, Sohini Mukherjee, Priyanka Jayal, Savita Singh, Anbalagan Anantharaj, Janmejay Singh, Souvick Chattopadhyay, Sreevatsan Raghavan, Mudita Gosain, Supriya Chauhan, Shweta Shrivas, Chaman Prasad, Sangeeta Chauhan, Neha Sharma, Pradipta Jana, Ramachandran Thiruvengadam, Pallavi Kshetrapal, Nitya Wadhwa, Bhabatosh Das, Gaurav Batra, Guruprasad Medigeshi, Devin Sok, Shinjini Bhatnagar, Pramod Kumar Garg, Jayanta Bhattacharya
Publikováno v:
Microbiology Spectrum. 11
Understanding the quality of immune repertoire triggered during natural infection can provide vital clues that form the basis for development of humoral immune response in some individuals capable of broadly neutralizing pan SARS-CoV-2 variants. We a
Autor:
Janmejay Singh, Aleksha Panwar, Anbalagan Anantharaj, Chitra Rani, Monika Bhardwaj, Parveen Kumar, Partha Chattopadhyay, Priti Devi, Ranjeet Maurya, Pallavi Mishra, Anil Kumar Pandey, Rajesh Pandey, Guruprasad R Medigeshi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b47144debf1a3a8add8427f9dca8cf2
https://doi.org/10.15252/rc.2022946475
https://doi.org/10.15252/rc.2022946475